In light of our above findings of APOL3-LDHA axis, we performed both in vitro and in vivo analysis to demonstrate the effect of APOL3-overexpressed CRC cells on the anti-tumor ability of CD8+ T cell. The gene discussed is CD8A; the disease is colorectal carcinoma.